Home › HIV › New Jersey › Newark
HIV clinical trials in Newark, NJ
5 studies for HIV are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecruitingPhase 3
- GSK Investigational Site, Newark
Positive Peers Intervention Clinical Trial
Recruiting
- Infectious Disease Practice- Rutgers University, Newark
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RecruitingPhase 2
- GSK Investigational Site, Newark
Menopausal HT for Women Living With HIV (HoT)
RecruitingPhase 4
- New Jersey Medical School Clinical Research Center CRS (31786), Newark
HIV Suicide Prevention With AI-DBT
Recruiting
- New Jersey Community Research Initiative, Newark
- RWJB Infectious Disease, Newark
About HIV
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
HIV trials in other cities
- Washington, DC22 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Miami, FL17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Chicago, IL14 studies
- Atlanta, GA14 studies
- Philadelphia, PA11 studies
- Boston, MA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
Other studies in Newark
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer13 studies
- Spinal Cord Injuries13 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Metastatic Cancer9 studies
- Cardiovascular Disease9 studies
- Cancer (all types)8 studies
- Melanoma8 studies
- Lung Cancer7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.